On Oct. 19, BRZ ANS introduced coverage for interstitial lung disease.
BRZ ANS published Normative Resolution ANS 682, amends supplementary health procedures list under Normative Resolution 465/2021 to expand mandatory coverage.
Bronchoscopy With Transbronchial Cryobiopsy Coverage
Mandatory coverage for bronchoscopy with transbronchial cryobiopsy for suspected interstitial lung disease requiring biopsy for histopathological diagnosis procedures.
Coverage applies when high-res. computed tomography is inconclusive or presents an indeterminate pattern for usual interstitial pneumonia in the patient being evaluated.
Annex I of Resolution 465/2021 is amended to include bronchoscopy with transbronchial cryobiopsy as procedure subject to utilization guidelines, requirements.
Annex II is also amended to establish mandatory coverage of the procedure for eligible patients with suspected interstitial lung disease under specified conditions.
Measure implements relevant provisions of Law 9.656/1998 governing supplementary health coverage and will be available through BRZ ANS institutional website.
Effectiveness
Normative Resolution 682 enters into effect on Nov. 3, 2026.
